Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This study will examine the efficacy and safety of pegaptanib sodium in Japanese patients
with wet-type AMD, in order to establish that there is no large difference in the efficacy
and the safety of the drug between Western and Japanese patients.